That observation encapsulates why chronic disease management as we practise it today is reactive rather than predictive.

With three-quarters of a century dedicated to advancing cardiovascular science and improving patient care, the ESC ...

Researchers at National Jewish Health have shown that subtle increases in lung scarring, detected by an artificial ...

Why are we so ill-prepared for the common cold? It’s not because the common cold has been neglected by scientists or vaccine ...

The FDA granted approval to nerandomilast, now Jascayd, for treating adults with idiopathic pulmonary fibrosis, marking the first treatment approved for this indication in more than 10 years, ...

After years of being told their crushing exhaustion might be “all in their head,” people with Myalgic ...

The biologics omalizumab, mepolizumab, benralizumab, and dupilumab have similar effectiveness in improving lung function in severe asthma.

Cognitive impairment levels in ICU patients who had acute hypoxemic respiratory failure were similar in those with PaO2 targets of 60 and 90 mm Hg.

Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced new research from more than 100 ...

Objective Certain leading medical organisations are considering alternatives to the Body Mass Index (BMI) as a predictor of the risk for non-communicable chronic disease (NCD) or death. Our objective ...